Treatment with EGF increases the length of S-phase after partial hepatectomy in rat, changing the activities of cdks

Cellular Physiology and Biochemistry

Volumn 13, Issue 4, 2003, Pages 239-248

  Alisi, Anna ^a   Spagnuolo, Silvana ^a   Leoni, Silvia ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Cell cycle; Cyclins; EGF; Liver regeneration; p21 cip1; p27 kip1

Indexed keywords

BIOLOGICAL MARKER; CYCLIN DEPENDENT KINASE; CYCLINE; EPIDERMAL GROWTH FACTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; LIVER CELL; MALE; MONITORING; NONHUMAN; PARTIAL HEPATECTOMY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; WESTERN BLOTTING;

EID: 0042164877     PISSN: 10158987     EISSN: None     Source Type: Journal    
DOI: 10.1159/000072427     Document Type: Article

References (44)

1. Carpenter G, Cohen S: Epidermal growth factor. J Biol Chem 1990;265:7709-7712.
2. Pai R, Tarnawsky A: Signal transduction cascades triggered by EGF receptor activation. Digestive disease and Sciences 1998;43:14S.
3. Loyer P, Cariou S, Glaise D, Bilodean M, Baffet G, Guguen-Guillouzo C: Growth factor dependence of progression through G1 and S phases of adult rat hepatocytes in vitro. J Biol Chem 1996;271:11484-11492.
4. Mele R, Marino M, Spagnuolo S, Figliola R, Mangiantini MT, Leoni S: Mitogenic signal of epidermal growth factor in chick embryo hepatocytes: role of PKCα. Cell Physiol Biochem 2000;10:209-218.
5. Leoni S, Spagnuolo S, Marino M, Terenzi F, Massimi M, Conti Devirgiliis L: Different signal transduction by epidermal growth factor may be responsible for the difference in modulation of amino acid transport between fetal and adult hepatocytes. J Cell Physiol 1993;155:549-555.
6. Marino M, Mele R, Spagnuolo S, Pulcinelli FM, Mangiantini MT, Leoni S: Epidermal growth factor regulates amino acid transport in chick embryo hepatocytes via protein kinase C. Exper Physiol 2000;85:363-369.
7. Incerpi S, Spagnuolo S, Terenzi F, Leoni S: EGF modulation of Na/H antiport in rat hepatocytes: different sensitivity in adult and fetal cells. Am J Physiol 1996;270:C841-C847.
8. Skov Olsen P, Boesby S, Kirkegaard P, Therkelsen K, Almdal T, Poulsen SS, Nexo E: Influence of epidermal growth factor on liver regeneration after partial hepatectomy in rats. Hepatology 1988;8:992-6.
9. Noguchi S, Ohba Y, Oka T: Influence of epidermal growth factor on liver regeneration after partial hepatectomy in mice. J Endocrinology 1991;128:425-431
10. Lambotte L, Saliez A, Triest S, Maiter D, Baranski A, Barker A, Li B: Effect of sialoadenectomy and epidermal growth factor administration on liver regeneration after partial hepatectomy. Hepatology 1997;25:607-612.
11. Michalopoulos GK, De Frances MC: Liver regeneration. Science 1997;276:60-66.
12. Steer CJ: Liver regeneration. FASEB J 1995;9:1396-1400.
13. Fausto N: Liver regeneration. J Hepatol 2000;32:19-31.
14. Wilkinson MG, Millar JBA: Control of the eukaryotic cell cycle by MAP kinase signaling pathways. FASEB J 2000;14:2147-2157.
15. Park JS, Qiao L, Gilfor D, Yang MY, Hylemon PB, Benz C, Darlington D, Firestone G, Fisher PB, Dent P: A role for both Ets and C/EBP transcription factors and mRNA stabilization in the MAPK-dependent increase in p21 (Cip-1/WAF1/mda6) protein levels in primary hepatocytes. Mol Biol Cell 2000;11:2915-2932.
16. Sherr CJ, Roberts JM: Inhibitors of mammalian G1 cyclin-dependent kinases. Genes and Dev 1995;9:1149-1163.
17. Morgan DO: Cyclin-dependent Kinase: Engines, Clocks, and Microprocessors. Annu Rev Cell Dev Biol 1997;13:261-291.
18. Sherr CJ, Roberts JM: CDK inhibitors: positive and negative regulators of G1-phase progression. Genes and Dev 1999;13:1501-1512.
19. Molinari M: Cell cycle checkpoints and their inactivation in human cancer. Cell Prolif 2000;33:261-274.
20. Loyer P, Glaise D, Cariou S, Baffet G, Meijer L, Guguen-Guillouzo C: Expression and activation of CDKs (1 and 2) and cyclins in the cell cycle progression during liver generation. J Biol Chem 1994;269:2491-2500.
21. Albrecht JH, Hu MY, Cerra FB: Distinct patterns of cyclin D1 regulation in models of liver regeneration and human liver. Biochem Biophys Res Commun 1995;209:648-655.
22. Trembley JH, Ebbert JO, Kren BT, Steer CJ: Differential Regulation of Cyclin B1 RNA and Protein Expression during Hepatocyte Growth in Vivo. Cell Growth & Differ 1996;7:903-916.
23. Kato A, Ota S, Bamba H, Wong RM, Ohmura E, Imai Y, Matsuzaki F: Regulation of cyclin D-dependent kinase activity in rat liver regeneration. Biochem Biophys Res Commun 1998;245:70-74.
24. Albrecht JH, Poon RY, Ahonen CL, Rieland BM, Deng C, Crary GS: Involvement of p21 and p27 in the regulation of CDK activity and cell progression in the regenerating liver. Oncogene 1998;16:2141-2150.
25. Albrecht JH, Rieland BM, Nelsen CJ, Ahonen CL: Regulation of G1 cyclin-dependent kinases in the liver: role of nuclear localization and p27 sequestration. Am J Physiol 1999;277:G1207-G1216.
26. Jaumot M, Estanyol JM, Serratosa J, Agell N, Bachs O: Activation of Cdk4 and Cdk2 during rat liver regeneration is associated with intranuclear rearrangements of cyclin-Cdk complexes. Hepatology 1999;29:385-395.
27. Kip1 with cyclin E-CDK2 during rat liver regeneration. J Hepatol 2000;32:1-9.
28. Marino M, Spagnuolo S, Cavallini M, Terenzi F, Mangiantini MT, Leoni S: EGF responsivness of hepatocytes after partial hepatectomy. Cell Signal 1996;8:555-559.
29. Wong Z, Flück S, Zhang L, Moon MF: Requirement for PLCγ1 enzymatic activity in growth factor induced mitogenesis. Mol Cell Biol 1999;18:590-597.
30. Higgins GM, Anderson RM: Experimental pathology of the liver. I. Restoration of the liver of the white rat following partial surgical removal. Arch Pathol 1931;12:186-202.
31. Thomas T, Balabhadrapathruni S, Gardner CR, Hong J, Faaland CA, Thomas J: Effects of Epidermal Growth Factor on MDA-MB-468 Breast Cancer Cells: Alterations in Polyamine Biosynthesis and the Expression of p21/CIP1/WAF1. J Cell Phys 1999;179:257-266.
32. 1 arrest mediated by an anti-epidermal growth factor receptor monoclonal antibody. Oncogene 1996;12:1397-1403.
33. Albrecht JH, Hansen L: Cyclin D1 Promotes Mitogen-independent Cell Cycle Progression in Hepatocytes Cell Growth & Differ 1999;10:397-404.
34. Kip1 CDK "inhibitors" are essential activators of cyclin D-dependent kinases in murine fibroblast. EMBO J 1999;18:1571-1583.
35. Parry DA, Mahony D, Wills K, Lees E: Cyclin D-CDK subunit arrangement is dependent on the availability of competing INK4 and p21 class inhibitors. Mol Cell Biol 1999;19:1775-1783.
36. Pibiri M, Ledda-Columbano M, Cossu C, Simbula G, Menegazzi M, Shinozuka H, Columbano A: Cyclin D1 is an early target in hepatocyte proliferation induced by thyroid hormone (T3). FASEB J 2001;15:1006-1013.
37. Loyer P, Cariou S, Glaise D, Bilodean M, Baffet G, Guguen-Guillouzo C: Growth factor dependence of progression through G1 and S phases of adult rat hepatocytes in vitro. J Biol Chem 1996;271:11484-11492.
38. Ekholm SV, Zickert P, Reed SI, Zetterberg A: Accumulation of cyclin E is not a prerequisite for passage through the restriction point. Mol Cell Biol 2001; 21:3256-3265.
39. Kamai T, Takagi K, Asami H, Ito Y, Oshima H, Yoshida KI: Decreasing of p27(Kip1) and cyclin E levels is associated with progression from superficial into invasive bladder cancer. Br J Cancer 2001;84:1242-1251.
40. Li JQ, Miki H, Ohmori M, Wu F, Funamoto Y: Expression of cyclin E and cyclin-dependent kinase 2 correlates with metastasis and prognosis in colorectal carcinoma. Hum Pathol 2001;32:945-953.
41. Weglarz TC, Sandgren EP: Timing of hepatocyte entry into DNA synthesis after partial hepatectomy is cell autonomous. PNAS 2000;97:12595-12600.
42. Wustefeld T, Rakemann T, Kubicka S, Manns MP, Trautwein C: Hyperstimulation with Interleukin 6 inhibits cell cycle progression after hepatectomy in mice. Hepatology 2000;3:514-522.
43. Besson A, Yong VW: Involvement of p21(Waf1/Cip1) in protein kinase C alpha-induced cell cycle progression. Mol Cell Biol 2000;20:4580-4590.
44. Hermanto U, Zong CS, Wang LH: ErbB2-overexpressing human mammary carcinoma cells display an increased requirement for the phosphatidylinositol 3-kinase signaling pathway in anchorage-independent growth. Oncogene 2001;20:7551-62.